Envoy Medical Advances Acclaim Cochlear Implant Trial
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
WHITE BEAR LAKE, Minnesota, June 30, 2026 Envoy Medical announced the submission of the first module of its Modular...
SUNNYVALE, Calif., June 5, 2026 BioCardia, Inc. announced that it has received official meeting minutes from the U.S. Food...
Minneapolis, USA, and Brisbane, Australia – November 3, 2025 Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) has announced...
